Product Images Bisoprolol Fumarate And Hydrochlorothiazide

This appears to be a label of medication named Bisoprolol Fumarate/Hctz 5/6.25 Tablet for oral consumption. It is manufactured by Edenbridge Pharmaceuticals LLC and is meant to be kept at room temperature. The label also contains instructions on safely storing the medicine and keeping it out of reach of children. The medicine comes in a container with 30 tablets, and the label includes the NDC (National Drug Code) number and the expiration date.*

The text provides data on Sitting Systolic/Diastolic Pressure (BP) and Heart Rate (HR) before and after the treatment for two studies. The first study compares the placebo and BSH6.25, and the second study compares Placebo, H625mg, B3/H62smg, and BI0/H625. The data shows the mean decrease in BP and increase or decrease in heart rate after 3.4 weeks of treatment. The text also gives information on drug effects, and observed mean change from baseline minus placebo.*

This is a table of the percentage of patients who experienced adverse events during a drug trial. The table lists adverse experiences by body system and shows the percentage for each experience and whether it was drug-related. Adverse experiences were reported for the cardiovascular, respiratory, body as a whole, central nervous system, musculoskeletal, psychiatric, and gastrointestinal body systems. The adverse experiences included in the table were bradycardia, arrhythmia, peripheral ischemia, chest pain, bronchospasm, cough, tinnitus, and insomnia, among others.*

The available text is showing a table of serum potassium data from US, which seems to be placebo-controlled. It includes mean change in potassium levels measured in mEq/L in the year 2004. It also displays the percentage of patients with hypokalemia. No further information is available.*